Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × ACT001 × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 2 tovorafenib 1 ribociclib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 Specimen Handling 1 Radiotherapy 1 PTC596 1 Magnetic Resonance Spectroscopy 1 Everolimus 1 Eflornithine 1 Diphtheria-Tetanus Vaccine 1 Diffusion Tensor Imaging 1 Automobiles 1 ACT001 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06838676 2026-03-27

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nationwide Children's Hospital

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡